D-Index & Metrics Best Publications
Microbiology
Austria
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 63 Citations 15,304 137 World Ranking 1718 National Ranking 6

Research.com Recognitions

Awards & Achievements

2023 - Research.com Microbiology in Austria Leader Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Surgery
  • Gene

Cornelia Lass-Flörl focuses on Microbiology, Voriconazole, Posaconazole, Aspergillosis and Amphotericin B. Her study involves Aspergillus, Aspergillus fumigatus, Drug resistance, Scedosporium and Cryptococcus, a branch of Microbiology. She is interested in Micafungin, which is a field of Voriconazole.

Her work in Posaconazole addresses subjects such as Internal medicine, which are connected to disciplines such as Surgery. Her Aspergillosis research is multidisciplinary, incorporating perspectives in Anidulafungin, Caspofungin and Intensive care medicine. Her research investigates the connection between Amphotericin B and topics such as Itraconazole that intersect with issues in Mycosis, Dermatology, Chromoblastomycosis, Pathognomonic and Phaeohyphomycosis.

Her most cited work include:

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. (751 citations)
  • ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (543 citations)
  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline (417 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of investigation include Microbiology, Aspergillosis, Aspergillus, Amphotericin B and Immunology. Cornelia Lass-Flörl has researched Aspergillosis in several fields, including Mycosis, Etest and Intensive care medicine. As part of one scientific family, Cornelia Lass-Flörl deals mainly with the area of Aspergillus, narrowing it down to issues related to the Antifungal, and often Susceptibility testing.

Her Amphotericin B study integrates concerns from other disciplines, such as Itraconazole, Neutropenia and Drug resistance. In her study, Gastroenterology is inextricably linked to Internal medicine, which falls within the broad field of Posaconazole. Her biological study spans a wide range of topics, including Fluconazole and Azole.

She most often published in these fields:

  • Microbiology (53.15%)
  • Aspergillosis (24.48%)
  • Aspergillus (24.48%)

What were the highlights of her more recent work (between 2014-2020)?

  • Immunology (17.48%)
  • Microbiology (53.15%)
  • Aspergillosis (24.48%)

In recent papers she was focusing on the following fields of study:

Her primary areas of study are Immunology, Microbiology, Aspergillosis, Intensive care medicine and Amphotericin B. Her studies in Immunology integrate themes in fields like Drug resistance and Invasive candidiasis. Many of her studies on Microbiology involve topics that are commonly interrelated, such as Virulence.

Her research integrates issues of Aspergillus fumigatus, Voriconazole, Caspofungin, Posaconazole and Combined Modality Therapy in her study of Aspergillosis. Her study in Voriconazole is interdisciplinary in nature, drawing from both Induction chemotherapy and Leukemia, Internal medicine, Transplantation. Her work carried out in the field of Intensive care medicine brings together such families of science as Mucormycosis, Pathology and Nomenclature.

Between 2014 and 2020, her most popular works were:

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline (417 citations)
  • ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients (247 citations)
  • Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. (212 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Pathology

Cornelia Lass-Flörl mainly investigates Aspergillosis, Intensive care medicine, Microbiology, Voriconazole and Immunology. Cornelia Lass-Flörl combines subjects such as Hematopoietic stem cell transplantation, Transplantation, Anidulafungin, Echinocandin and Targeted therapy with her study of Aspergillosis. Her studies deal with areas such as Leukemia, Nomenclature and Pathology as well as Intensive care medicine.

Aspergillus fumigatus, Antibiotic resistance, Azole resistance, Aspergillus and Invasive candidiasis are subfields of Microbiology in which her conducts study. Her Voriconazole research integrates issues from Internal medicine and Induction chemotherapy. Her Immunology research incorporates elements of Autophagy and Anakinra.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino.
Clinical Microbiology and Infection (2012)

1153 Citations

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning.
Clinical Microbiology and Infection (2018)

828 Citations

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

O.A. Cornely;S. Arikan-Akdagli;E. Dannaoui;A.H. Groll.
Clinical Microbiology and Infection (2014)

645 Citations

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

J Maertens;O Marchetti;R Herbrecht;O A Cornely.
Bone Marrow Transplantation (2011)

572 Citations

Changing epidemiology of systemic fungal infections

Malcolm Richardson;C Lass-Flörl.
Clinical Microbiology and Infection (2008)

539 Citations

The changing face of epidemiology of invasive fungal disease in Europe

Cornelia Lass-Flörl.
Mycoses (2009)

469 Citations

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*

Maiken C. Arendrup;Manuel Cuenca-Estrella;Cornelia Lass-Flörl;William Hope.
Clinical Microbiology and Infection (2012)

465 Citations

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

Frederic Tissot;Samir G. Agrawal;Livio Pagano;Georgios Petrikkos.
Haematologica (2017)

454 Citations

ESCMID guideline for the diagnosis and management of Candida diseases 2012:diagnostic procedures

M. Cuenca-Estrella;P. E Verweij;M. C Arendrup;S. Arikan-Akdagli.
Clinical Microbiology and Infection (2012)

408 Citations

Antifungal drug resistance among Candida species: mechanisms and clinical impact

Maurizio Sanguinetti;Brunella Posteraro;Cornelia Lass-Flörl.
Mycoses (2015)

384 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Cornelia Lass-Flörl

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 128

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 126

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 125

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 113

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 96

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 95

David W. Denning

David W. Denning

University of Manchester

Publications: 94

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 86

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 85

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 82

Eric Dannaoui

Eric Dannaoui

Université Paris Cité

Publications: 79

Monica A. Slavin

Monica A. Slavin

Peter MacCallum Cancer Centre

Publications: 77

Jesús Guinea

Jesús Guinea

Hospital General Universitario Gregorio Marañón

Publications: 73

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 68

Russell E. Lewis

Russell E. Lewis

University of Bologna

Publications: 66

Maurizio Sanguinetti

Maurizio Sanguinetti

Catholic University of the Sacred Heart

Publications: 63

Trending Scientists

Theodore C. Bergstrom

Theodore C. Bergstrom

University of California, Santa Barbara

H. De Meyer

H. De Meyer

Ghent University

Kaido Tammeveski

Kaido Tammeveski

University of Tartu

Günter Huber

Günter Huber

Universität Hamburg

Wilfried Sigle

Wilfried Sigle

Max Planck Society

John R.W. Yates

John R.W. Yates

University of Cambridge

Thomas W. Kuyper

Thomas W. Kuyper

Wageningen University & Research

Gary Van Domselaar

Gary Van Domselaar

Public Health Agency of Canada

Ueli Suter

Ueli Suter

École Polytechnique Fédérale de Lausanne

Richard L. Whitman

Richard L. Whitman

United States Geological Survey

Stefano Albanese

Stefano Albanese

University of Naples Federico II

David Poeppel

David Poeppel

Max Planck Society

Cliff H. Summers

Cliff H. Summers

University of South Dakota

Peter R. Cavanagh

Peter R. Cavanagh

University of Washington

Lawton R. Burns

Lawton R. Burns

University of Pennsylvania

Benjamin Davis

Benjamin Davis

Food and Agriculture Organization of the United Nations

Something went wrong. Please try again later.